Top Stocks To Buy Today As Investors Shift From Stay-At-Home Stocks

Dow continued its surge after Pfizer PFE and BioNTech revealed yesterday that studies show that their COVID-19 vaccine is more than 90% effective. These results were better than anyone expected as Dr. Anthony Fauci said that a 50-60% efficacy rate would be “acceptable.” However, with this “light at the end of the tunnel,” investors have been quick to run towards recovery stocks and rotate out of tech and “stay-at-home” winners. The Dow traded 74 points higher, or 0.3% while the S&P 500 dipped 0.4% and the Nasdaq NDAQ slid 0.9%. Amazon AMZN was down 2.5% after falling 5% on Monday, and Zoom dropped another 2% after declining by 17% on Monday. Recovery names led the gains with Chevron CVX and Exxon Mobil XOM up more than 1%, and Boeing BA up 1.8%. For investors looking to make the most of this rally, the deep learning algorithms at Q.ai have crunched the data to give you a set of Top Buys. Our Artificial Intelligence (“AI”) systems assessed each firm on parameters of Technicals, Growth, Low Volatility Momentum, and Quality Value to find the best long plays.

Sign up for the free Forbes AI Investor newsletter here to join an exclusive AI investing community and get premium investing ideas before markets open.

Recommended For You

Akamai Technologies Inc (AKAM)

Akamai Technologies AKAM is our first Top Buy of the day. Akamai is an innovative digital intelligence and cloud computing provider. Our AI systems rated the company C in Technicals, B in Growth, B in Low Volatility Momentum, and A in Quality Value. The stock closed down 2.32% to $99.27 on volume of 2,168,581 vs its 10-day price average of $98.95 and its 22-day price average of $105.15, and is up 13.27% for the year. Revenue grew by 7.96% in the last fiscal year and grew by 25.51% over the last three fiscal years, Operating Income grew by 18.94% in the last fiscal year and grew by 73.77% over the last three fiscal years, and EPS grew by 17.61% in the last fiscal year and grew by 164.41% over the last three fiscal years. Revenue was $2893.62M in the last fiscal year compared to $2489.04M three years ago, Operating Income was $573.52M in the last fiscal year compared to $392.55M three years ago, EPS was $2.9 in the last fiscal year compared to $1.29 three years ago, and ROE was 13.96% in the last year compared to 6.76% three years ago. Forward 12M Revenue is expected to grow by 4.73% over the next 12 months, and the stock is trading with a Forward 12M P/E of 18.57.

MORE FROM FORBESAkamai Technologies (AKAM)

Arrow Electronics Inc (ARW)

Arrow Electronics ARW is our second Top Buy of the day. The Fortune 500 company specializes in distribution and value added services relating to electronic components and computer products. Our AI systems Arrow Electronics C in Technicals, B in Growth, A in Low Volatility Momentum, and A in Quality Value. The stock closed up 1.13% to $85.74 on volume of 677,374 vs its 10-day price average of $80.8 and its 22-day price average of $82.23, and is down 0.06% for the year. Revenue grew by 3.78% over the last three fiscal years, while EPS grew by -335.94% in the last fiscal year and grew by 28.62% over the last three fiscal years. Revenue was $28916.85M in the last fiscal year compared to $26554.56M three years ago, Operating Income was $835.99M in the last fiscal year compared to $1003.53M three years ago, EPS was $(2.44) in the last fiscal year compared to $4.48 three years ago, and ROE was (3.91%) in the last year compared to 8.61% three years ago. Forward 12M Revenue is expected to grow by 5.1% over the next 12 months, and the stock is trading with a Forward 12M P/E of 9.71.

MORE FROM FORBESArrow Electronics (ARW)

FMC Corp (FMC)

Chemical manufacturing company FMC Corp FMC is our next Top Buy of the day. The Philadelphia based company originated as an insecticide producer and now offers various services ranging from agriculture, health, and sustainable energy. Our AI systems rated Fmc Corp B in Technicals, B in Growth, B in Low Volatility Momentum, and A in Quality Value. The stock closed up 1.09% to $109.84 on volume of 804,832 vs its 10-day price average of $105.72 and its 22-day price average of $106.93, and is up 11.52% for the year. Revenue grew by 1.68% in the last fiscal year and grew by 85.18% over the last three fiscal years, Operating Income grew by 4.69% in the last fiscal year and grew by 193.27% over the last three fiscal years, and EPS grew by 5.57% in the last fiscal year. Revenue was $4609.8M in the last fiscal year compared to $2531.2M three years ago, Operating Income was $1070.4M in the last fiscal year compared to $382.1M three years ago, EPS was $3.62 in the last fiscal year compared to $3.99 three years ago, and ROE was 18.83% in the last year compared to (5.66%) three years ago. Forward 12M Revenue is expected to grow by 4.68% over the next 12 months, and the stock is trading with a Forward 12M P/E of 15.34.

MORE FROM FORBESFMC (FMC)

Herbalife Nutrition Ltd (HLF)

Nutrition and weight management company Herbalife Nutrition is our fourth Top Buy of the day. Herbalife develops and sells dietary supplements, and is well known for how they market their products. Our AI systems rated the company B in Technicals, A in Growth, B in Low Volatility Momentum, and A in Quality Value. The stock closed down 8.46% to $44.39 on volume of 1,974,899 vs its 10-day price average of $46.86 and its 22-day price average of $47.98, and is down 5.95% for the year. Revenue grew by 9.73% in the last fiscal year and grew by 20.86% over the last three fiscal years, Operating Income grew by 6.63% in the last fiscal year and grew by 0.41% over the last three fiscal years, and EPS grew by 17.01% in the last fiscal year and grew by 99.56% over the last three fiscal years. Revenue was $4877.1M in the last fiscal year compared to $4427.7M three years ago, Operating Income was $581.1M in the last fiscal year compared to $617.1M three years ago, and EPS was $2.2 in the last fiscal year compared to $1.29 three years ago. Forward 12M Revenue is expected to grow by 3.35% over the next 12 months, and the stock is trading with a Forward 12M P/E of 11.36.

MORE FROM FORBESHerbalife (HLF)

Procter & Gamble Co (PG)

Consumer products giant Procter & Gamble PG is our final Top Buy of the day. The multinational conglomerate focuses on personal health/consumer health, hygiene products, and consumer goods. Procter & Gamble’s subsidiaries also consist of well known brands such as Gillette, Braun, Duracell, and more. Our AI systems rated the company C in Technicals, B in Growth, A in Low Volatility Momentum, and B in Quality Value. The stock closed down 3.66% to $137.99 on volume of 12,660,119 vs its 10-day price average of $139.86 and its 22-day price average of $141.28, and is up 14.57% for the year. Revenue grew by 2.14% in the last fiscal year and grew by 8.44% over the last three fiscal years, Operating Income grew by 5.61% in the last fiscal year and grew by 27.82% over the last three fiscal years, and EPS grew by 5.47% in the last fiscal year and grew by 42.58% over the last three fiscal years. Revenue was $70950.0M in the last fiscal year compared to $66832.0M three years ago, Operating Income was $16172.0M in the last fiscal year compared to $13363.0M three years ago, EPS was $4.96 in the last fiscal year compared to $3.67 three years ago, and ROE was 27.74% in the last year compared to 18.15% three years ago. Forward 12M Revenue is expected to grow by 0.41% over the next 12 months, and the stock is trading with a Forward 12M P/E of 24.57.

MORE FROM FORBESProcter & Gamble (PG)

Liked what you read? Sign up for our free Forbes AI Investor Newsletter here to get AI driven investing ideas weekly. For a limited time, subscribers can join an exclusive slack group to get these ideas before markets open.

Comments are closed.